US$ 23.06
is yerba mate a glp 1 agonist GLP-1: Genetic Variants Related to GLP-1 RA Medications Unlocking the Health Benefits of
Description
The case for incretin therapy was once again dismissed in 1950 by Morton Grossman, one of Ivys former students

Synthetic forms of glucagon are available for treatment of severe acute hypoglycemia, including the intramuscular Gvoke HypoPen and a nasal powder called Baqsimi [BAK see mee]come back to see me

Ann Intern Med (2022) 175:1392400
It behaved like GLP-1, but lasted much longer

Here's what the clinical data says about it

Weight loss can also help to control and prevent non-alcoholic fatty liver disease (NAFLD) another condition associated with obesity
